Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1F.

Molecular therapy : the journal of the American Society of Gene Therapy
Authors
Abstract

Usher syndrome type 1F (USH1F), characterized by congenital lack of hearing and balance and by progressive loss of vision, is caused by mutations in the PCDH15 gene. Within the Ashkenazi population, a recessive truncation mutation accounts for a large proportion of USH1F cases. The truncation is caused by a single C→T mutation, which converts an arginine codon to a stop (R245X). To test the potential for base editors to revert this mutation, we developed a humanized Pcdh15 mouse model for USH1F. Mice homozygous for the R245X mutation were deaf and exhibited profound balance deficits, while heterozygous mice were unaffected. Here we show that an adenine base editor (ABE) is capable of reverting the R245X mutation to restore the PCDH15 sequence and function. We packaged a split-intein ABE into dual AAV vectors and delivered them into cochleas of neonatal USH1F mice. Hearing was not restored in a Pcdh15 constitutive null mouse despite base editing, perhaps because of early disorganization of cochlear hair cells. However, injection of vectors encoding the split ABE into a late-deletion conditional Pcdh15 knockout rescued hearing. This study demonstrates the ability of an ABE to correct the PCDH15 R245X mutation in the cochlea and to restore hearing.

Year of Publication
2023
Journal
Molecular therapy : the journal of the American Society of Gene Therapy
Date Published
06/2023
ISSN
1525-0024
DOI
10.1016/j.ymthe.2023.06.007
PubMed ID
37312453
Links